GHK-Cu and skin claims: what the evidence supports

A recent TikTok from Dr. Daniel Sugai playfully celebrates being in your 30s, with a skincare routine hashtag that hints at anti-aging. The clip doesn't explicitly name GHK-Cu, but the context of millennial skincare and anti-aging has led many viewers to associate it with copper peptide serums. The social claim, as interpreted, is that GHK-Cu is a well-supported, evidence-based ingredient for reducing visible aging in your 30s.

What the research neighborhood actually covers

GHK-Cu (copper tripeptide-1) has been studied for decades, primarily for its roles in wound healing and tissue remodeling. In vitro and some animal studies suggest it can stimulate collagen synthesis, promote angiogenesis, and modulate inflammation. These mechanisms are often cited as the basis for anti-aging claims. However, human clinical trials specifically measuring wrinkle reduction, skin elasticity, or photodamage reversal are limited. A few small studies have shown modest improvements in skin texture and fine lines, but the evidence base is far from robust. Most dermatologists agree that GHK-Cu may have a supportive role in skin health, but it is not a proven substitute for retinoids or sunscreen.

Limits of the evidence

Key limitations include: small sample sizes, short durations, and lack of standardized formulations. The concentration of GHK-Cu in cosmetic products varies widely, and stability can be an issue. Moreover, many studies are industry-funded or use combination formulas, making it hard to isolate GHK-Cu's specific effect. The TikTok's lighthearted tone doesn't address these nuances, which is typical of social media content.

Research-use caveat

For researchers and laboratory professionals, GHK-Cu is a valuable tool for studying cell signaling, wound healing, and extracellular matrix remodeling. It is not intended for human consumption or cosmetic use in a research context. Any product sold for research use only (RUO) must be handled with appropriate safety protocols. The peptide's potential in dermatology is promising, but translating bench findings to clinical claims requires rigorous, peer-reviewed trials.

Open the full video fact-check page (transcript, takeaways, embedded clip).